Literature DB >> 13372954

Differential characteristics in vitro and in vivo of several substrains of BCG. III. Multiplication and survival in vivo.

R J DUBOS, C H PIERCE, W B SCHAEFER.   

Abstract

Keywords:  MYCOBACTERIUM TUBERCULOSIS BOVIS

Mesh:

Year:  1956        PMID: 13372954     DOI: 10.1164/artpd.1956.74.5.683

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN: 0096-0381


× No keyword cloud information.
  14 in total

Review 1.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

2.  Salmonellosis in orally infected specific pathogen-free C57B1 mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

3.  Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

4.  Relative immunogenicity of streptomycin-sensitive and -resistant strains of BCG.

Authors:  F M Collins; V Montalbine
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

5.  Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.

Authors:  Scott T Nolan; Gyanu Lamichhane
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

6.  Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

Authors:  W H de Jong; P A Steerenberg; J G Kreeftenberg; R H Tiesjema; W Kruizinga; L M van Noorle Jansen; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70.

Authors:  K Miura; S Nagai; M Kinomoto; S Haga; T Tokunaga
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Why is long-term therapy required to cure tuberculosis?

Authors:  Lynn E Connolly; Paul H Edelstein; Lalita Ramakrishnan
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

9.  Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Authors:  Shanmugalakshmi Sadagopal; Miriam Braunstein; Cynthia C Hager; Jie Wei; Alexandria K Daniel; Markian R Bochan; Ian Crozier; Nathaniel E Smith; Hiriam O Gates; Louise Barnett; Luc Van Kaer; James O Price; Timothy S Blackwell; Spyros A Kalams; Douglas S Kernodle
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

10.  Measurement of resistance to experimental tuberculosis in albino mice. The immune phase.

Authors:  R Costello; T Izumi
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.